Evidence map›Paper›PMID 29802426›Full record

ArticleCancer immunology, immunotherapy : CII2018

Regulatory NK1.1

Zhijie Lin, Sen Han, Xingxing Qian, Chunxia Hu, Weiming Xiao, Li Qian, Yu Zhang, Yanbing Ding, Xiaoqin Jia, Guoqiang Zhu and 1 more

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancer immunology, immunotherapy : CII, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Low miR-16 expression induces regulatory CD4American journal of cancer research · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Zhijie LinDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001, People's Republic of China.
Sen HanDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001, People's Republic of China.
Xingxing QianDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001, People's Republic of China.
Chunxia HuDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001, People's Republic of China.
Weiming XiaoDepartment of Gastroenterology, Affiliated Hospital, Yangzhou University, Yangzhou, People's Republic of China.
Li QianDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001, People's Republic of China.
Yu ZhangJiangsu Key Laboratory of Zoonosis, Yangzhou University, 48 E. Wenhui Road, Yangzhou, 225009, People's Republic of China.
Yanbing DingDepartment of Gastroenterology, Affiliated Hospital, Yangzhou University, Yangzhou, People's Republic of China.
Xiaoqin JiaJiangsu Key Laboratory of Integrated Traditional Chinese and Western Medicine for Prevention and Treatment of Senile Diseases, Yangzhou University, Yangzhou, People's Republic of China.
Guoqiang ZhuJiangsu Key Laboratory of Zoonosis, Yangzhou University, 48 E. Wenhui Road, Yangzhou, 225009, People's Republic of China. yzgqzhu@yzu.edu.cn.
Weijuan GongDepartment of Immunology, Institute of Translational Medicine, Medical College, Yangzhou University, 11 Huaihai Road, Yangzhou, 225001, People's Republic of China. wjgong@yzu.edu.cn.ORCID http://orcid.org/0000-0002-8543-1314
Yangzhou University · CN

Funding

Collaborative Fund of Yangzhou University and Yangzhou municipality 2012038-5National Natural Science Foundation of China 81172785National Natural Science Foundation of China 81273214National Natural Science Foundation of China 81471547National Natural Science Foundation of China 81671547Natural Science Fund of Jiangsu Province BK2008215Natural Science Fund of Jiangsu Province BK2011449Social development fund of Yangzhou municipality YZ2014179
6 · The paper itself

Abstract

Regulatory T cells play critical roles in self-tolerance and tumor evasion. CD4

Indexed as

AdenocarcinomaAnimalsAntigens, LyCD4 AntigensColonic NeoplasmsDisease Models, AnimalHumansMiceMice, Inbred C57BLMice, TransgenicNK Cell Lectin-Like Receptor Subfamily BNK Cell Lectin-Like Receptor Subfamily KT-Lymphocytes, RegulatoryT-Lymphocyte SubsetsAntigens, LyCD4 AntigensKlrb1c protein, mouseKlrk1 protein, mouseNK Cell Lectin-Like Receptor Subfamily BNK Cell Lectin-Like Receptor Subfamily KCD4NK1.1NKG2DRegulatory T cellTGF-βTumor immunity

Identifiers

PMID29802426
PMCPMC11028319
OpenAlexW2803856501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.